Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Diabetologia|March 31, 2017
Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD<sub>65</sub>-induced immune responseBeatriz Tavira, Mikael Cheramy, Stina Axelsson, et al.
Frontiers in Immunology|November 9, 2020
Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes PatientsRosaura Casas, Fabrícia Dietrich, Hugo Barcenilla, et al.
Pharmacogenetics and Genomics|June 20, 2013
A search for new CYP3A4 variants as determinants of tacrolimus dose requirements in renal-transplanted patientsBeatriz Tavira, Eliecer Coto, Carmen Diaz-Corte, et al.
Diabetes/Metabolism Research and Reviews|October 6, 2021
Immune response differs between intralymphatic or subcutaneous administration of GAD-alum in individuals with recent onset type 1 diabetesFabrícia Dietrich, Hugo Barcenilla, Beatriz Tavira, et al.
The Journal of Clinical Endocrinology and Metabolism|May 28, 2019
Human-Specific Function of IL-10 in Adipose Tissue Linked to Insulin ResistanceJuan R Acosta, Beatriz Tavira, Iyadh Douagi, et al.
Cardiovascular Diabetology|April 12, 2023
Adipose tissue specific CCL18 associates with cardiometabolic diseases in non-obese individuals implicating CD4<sup>+</sup> T cellsNarmadha Subramanian, Kaisa Hofwimmer, Beatriz Tavira, et al.
Gene|January 22, 2014
Mitochondrial DNA haplogroups and risk of new-onset diabetes among tacrolimus-treated renal transplanted patientsBeatriz Tavira, Juan Gómez, Carmen Díaz-Corte, et al.
Journal of Human Genetics|February 13, 2015
The donor ABCB1 (MDR-1) C3435T polymorphism is a determinant of the graft glomerular filtration rate among tacrolimus treated kidney transplanted patientsBeatriz Tavira, Juan Gómez, Carmen Díaz-Corte, et al.
Kidney International Supplements|July 17, 2014
Pharmacogenetics of tacrolimus: ready for clinical translation?Eliecer Coto, Beatriz Tavira, Beatriz Suárez-Álvarez, et al.
Acta Diabetologica|January 31, 2022
Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial)Rosaura Casas, Fabrícia Dietrich, Sara Puente-Marin, et al.
Pageof 5